Human umbilical cord blood‑derived mesenchymal stem cell transplantation for the treatment of spinal cord injury

Cui,Bingzhou; Li,En; Yang,Bo; Wang,Bo

doi:10.3892/etm.2014.1608

Human umbilical cord blood‑derived mesenchymal stem cell transplantation for the treatment of spinal cord injury

Authors:
- Bingzhou Cui
- En Li
- Bo Yang
- Bo Wang
View Affiliations

Affiliations: Department of Neurosurgery, Zhengzhou People's Hospital, Zhengzhou, Henan 450003, P.R. China, Department of Neurosurgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450003, P.R. China
Published online on: March 6, 2014 https://doi.org/10.3892/etm.2014.1608
Pages: 1233-1236

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of human umbilical cord blood‑derived mesenchymal stem cell (HUCB‑MSC) transplantation on the functional restoration of spinal cord injury (SCI). A total of 46 adult Wistar rats were randomly divided into three groups: Injury (n=15), control (n=15) and transplantation (n=16). A SCI model was established using the modified Allen's method (vulnerating energy, 25 g/cm). The rats in the control and transplantation groups were injected at the site of the injury with physiological saline and HUCB-MSC suspension, respectively. At week one, two and four following treatment, the behavior of the rats was evaluated using the Basso, Beattie, Bresnahan locomotor rating scale. In addition, immunohistochemistry (IHC) was performed on samples from the rats that had been sacrificed four weeks subsequent to the treatment. Recovery of the spinal cord nerve function was identified to be significantly different at week two and four following treatment (P<0.05), and IHC identified that at week four following treatment novel nerve cells were being produced. Thus, transplantation of HUCB‑MSCs promoted the recovery of the damaged function of spinal cord nerves in rats with SCI.

View Figures

View References

1	Akiyama Y, Honmou O, Kato T, Uede T, Hashi K and Kocsis JD: Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord. Exp Neurol. 167:27–39. 2001. View Article : Google Scholar : PubMed/NCBI
2	Blesch A, Lu P and Tuszynski MH: Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull. 57:833–838. 2002. View Article : Google Scholar : PubMed/NCBI
3	Einstein O and Ben-Hur T: The changing face of neural stem cell therapy in neurological diseases. Arch Neurol. 65:452–456. 2008. View Article : Google Scholar : PubMed/NCBI
4	Girard C, Bemelmans AP, Dufour N, et al: Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci. 25:7924–7933. 2005. View Article : Google Scholar : PubMed/NCBI
5	Goldman S: Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol. 23:862–871. 2005. View Article : Google Scholar : PubMed/NCBI
6	Kuh SU, Cho YE, Yoon DH, Kim KN and Ha Y: Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien). 147:985–992. 2005. View Article : Google Scholar : PubMed/NCBI
7	Kwon BK, Fisher CG, Dvorak MF and Tetzlaff W: Strategies to promote neural repair and regeneration after spinal cord injury. Spine (Phila Pa 1976). 30(17 Suppl): S3–S13. 2005. View Article : Google Scholar : PubMed/NCBI
8	López-Vales R, Forés J, Verdú E and Navarro X: Acute and delayed transplantation of olfactory ensheathing cells promote partial recovery after complete transaction of the spinal cord. Neurobiol Dis. 21:57–68. 2006.PubMed/NCBI
9	Nakamura M, Toyama Y and Okano H: Transplantation of neural stem cells for spinal cord injury. Rinsho Shinkeigaku. 45:874–876. 2005.(In Japanese).
10	Rizek PN and Kawaja MD: Cultures of rat olfactory ensheathing cells are contaminated with Schwann cells. Neuroreport. 17:459–462. 2006. View Article : Google Scholar : PubMed/NCBI
11	Deumens R, Koopmans GC, Lemmens M, et al: Neurite outgrowth promoting effects of enriched and mixed OEC/ONF cultures. Neurosci Lett. 397:20–24. 2006. View Article : Google Scholar : PubMed/NCBI
12	Zhao ZM, Li HJ, Liu HY, et al: Intraspinal transplantation of CD34⁺ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant. 13:113–122. 2004.
13	Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D and Schwab ME: Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:498–501. 1995. View Article : Google Scholar : PubMed/NCBI
14	Bregman BS, McAtee M, Dai HN and Kuhn PL: Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol. 148:475–494. 1997. View Article : Google Scholar : PubMed/NCBI
15	Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N and Stokes BT: Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after exprimental spinal cord injury. Exp Neurol. 158:351–365. 1999. View Article : Google Scholar
16	Kishk NA, Gabr H, Hamdy S, et al: Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair. 24:702–708. 2010. View Article : Google Scholar : PubMed/NCBI
17	Pal R, Venkataramana NK, Bansal A, et al: Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy. 11:897–911. 2009. View Article : Google Scholar : PubMed/NCBI
18	Saito F, Nakatani T, Iwase M, et al: Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma. 64:53–59. 2008. View Article : Google Scholar : PubMed/NCBI
19	Chiu B, Wan JZ, Abley D and Akabutu J: Induction of vascular endothelial phenotype and cellular proliferation from human cord blood stem cells cultured in simulated microgravity. Acta Astronaut. 56:918–922. 2005. View Article : Google Scholar : PubMed/NCBI
20	Hong SH, Gang EJ, Jeong JA, et al: In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun. 330:1153–1161. 2005. View Article : Google Scholar : PubMed/NCBI
21	Jurga M, Markiewicz I, Sarnowska A, et al: Neurogenic potential of human umbilical cord blood: neural-like stem cells depend on previous long-term culture conditions. J Neurosci Res. 83:627–637. 2006. View Article : Google Scholar : PubMed/NCBI
22	Walczak P, Chen N, Eve D, et al: Long term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice. Brain Res Bull. 74:155–163. 2007. View Article : Google Scholar : PubMed/NCBI
23	El-Badri NS, Hakki A, Saporta S, et al: Cord blood mesenchymal stem cells: Potential use in neurological disorders. Stem Cells Dev. 15:497–506. 2006. View Article : Google Scholar : PubMed/NCBI
24	Ankeny DP, McTigue DM and Jakeman LB: Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol. 190:17–31. 2004. View Article : Google Scholar : PubMed/NCBI
25	Mansilla E, Marin GH, Sturla F, et al: Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplant Proc. 37:292–294. 2005. View Article : Google Scholar : PubMed/NCBI
26	Schultz SS: Adult stem cell application in spinal cord injury. Curr Drug Targets. 6:63–73. 2005. View Article : Google Scholar : PubMed/NCBI
27	Harris DT: Non-haematological uses of cord blood stem cells. Br J Haematol. 147:177–184. 2009. View Article : Google Scholar : PubMed/NCBI
28	Kim SU and de Vellis J: Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res. 87:2183–2200. 2009. View Article : Google Scholar : PubMed/NCBI
29	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
30	Tomita S, Mickle DA, Weisel RD, et al: Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 123:1132–1140. 2002. View Article : Google Scholar : PubMed/NCBI
31	Wang TT, Tio M, Lee W, Beerheide W and Udolph G: Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem Biophys Res Commun. 357:1021–1027. 2007. View Article : Google Scholar : PubMed/NCBI
32	Pal R, Gopinath C, Rao NM, et al: Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy. 12:792–806. 2010. View Article : Google Scholar : PubMed/NCBI
33	Bossolasco P, Cova L, Calzarossa C, et al: Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp Neurol. 193:312–325. 2005. View Article : Google Scholar : PubMed/NCBI
34	Bjugstad KB, Redmond DE Jr, Teng YD, et al: Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Cell Transplant. 14:183–192. 2005. View Article : Google Scholar
35	Garbuzova-Davis S, Willing AE, Saporta S, et al: Novel cell therapy approaches for brain repair. Prog Brain Res. 157:207–222. 2006. View Article : Google Scholar
36	Leu S, Lin YC, Yuen CM, et al: Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med. 8:632010. View Article : Google Scholar : PubMed/NCBI
37	Djouad F, Delorme B, Maurice M, et al: Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther. 9:R332007. View Article : Google Scholar : PubMed/NCBI
38	Crigler L, Robey RC, Asawachaicharn A, Gaupp D and Phinney DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 198:54–64. 2006. View Article : Google Scholar : PubMed/NCBI